San Antonio Report: GLP-1 drugs revolutionize obesity and diabetes care in San Antonio
San Antonio Report: GLP-1 drugs revolutionize obesity and diabetes care in San Antonio
Share This Story
Newsroom health conditions id
193
MarketWatch (Dow Jones): Can popular diabetes and weight-loss drugs slow vascular dementia?
MarketWatch (Dow Jones): Can popular diabetes and weight-loss drugs slow vascular dementia?
Share This Story
KENS 5: UT Health San Antonio now has $4 million to launch a first-of-its-kind study on diabetes and obesity
KENS 5: UT Health San Antonio now has $4 million to launch a first-of-its-kind study on diabetes and obesity
Share This Story
EurekaAlert!: UT Health San Antonio leads $4 million study on glucagon hormone’s role in diabetes, obesity
EurekaAlert!: UT Health San Antonio leads $4 million study on glucagon hormone’s role in diabetes, obesity
Share This Story
KVDA-TV (Telemundo): UT Health prepares health fair to raise awareness about diabetes
KVDA-TV (Telemundo): UT Health prepares health fair to raise awareness about diabetes
Share This Story